In the case of small-molecule drugs, MC degranulation occurs under in vitro experimental conditions, which may cause MRGPRX2-related systemic pseudo-allergic reactions, particularly acute urticaria and anaphylaxis (9, 10). Here, MRGPRX2 is linked to anaphylaxis.